Stay updated with breaking news from Macrogenics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frazier Life Sciences Management L.P. boosted its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,401,704 shares of the biopharmaceutical company’s stock after purchasing an additional […]
Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […]
Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX). Such...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX). Such...